Endogenous Benzodiazepine Receptor Ligands in Human and Animal Hepatic Encephalopathy

Abstract: The role of endogenous benzodiazepine receptor ligands in the pathogenesis of hepatic encephalopathy was studied in humans and in rat models of hepatic encephalopathy. Endogenous benzodiazepine ligands were extracted from rat brain and human CSF by acid treatment and purification by HPLC. Detection and partial characterization of these endogenous benzodiazepine ligands were carried out using both radioreceptor binding assays and radioimmunoassays with anti‐benzodiazepine antibodies. Four different benzodiazepine receptor ligands were identified in human and rat tissue, two of which may be diazepam and desmethyldiazepam, based on elution profiles and anti‐benzodiazepine antibody reactivity. Human CSF and serum from patients with hepatic encephalopathy contained ∼ 10 times more endogenous benzodiazepine receptor ligand than CSF from controls or nonencephalopathic patients with liver disease. The levels of brain benzodiazepine receptor ligand compounds were also increased ∼ 10‐fold in rats suffering from fulminant hepatic failure, but not in rats with portacaval shunts, a model of chronic hepatic disease. The increased concentrations of these substances could be behaviorally significant and may contribute to the pathogenesis of hepatic encephalopathy.

[1]  L. Pannell,et al.  Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. , 1991, The New England journal of medicine.

[2]  P. Skolnick,et al.  Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands , 1990, Hepatology.

[3]  P. Dodd,et al.  Plasma gaba‐like activity in rats with hepatic encephalopathy is due to gaba and taurine , 1990, Hepatology.

[4]  J. Medina,et al.  Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. , 1989, Biochemical and biophysical research communications.

[5]  P. Skolnick,et al.  GABAA Receptor Complex in an Experimental Model of Hepatic Encephalopathy: Evidence for Elevated Levels of an Endogenous Benzodiazepine Receptor Ligand , 1989, Journal of neurochemistry.

[6]  P. Meier,et al.  Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. , 1989, Gastroenterology.

[7]  U. Klotz,et al.  Detection of desmethyldiazepam and diazepam in brain of different species and plants. , 1989, Biochemical pharmacology.

[8]  J. Deckert,et al.  Autoradiographic analysis of GABA‐benzodiazepine receptors in an animal model of acute hepatic encephalopathy , 1989, Hepatology.

[9]  A. Guidotti,et al.  Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy , 1989, Annals of neurology.

[10]  H. Lassmann,et al.  Hepatic encephalopathy in thioacetamide‐induced acute liver failure in rats: Characterization of an improved model and study of amino acid‐ergic neurotransmission , 1989, Hepatology.

[11]  A. Guidotti,et al.  ENDOGENOUS BENZODIAZEPINES IN HEPATIC ENCEPHALOPATHY , 1989, The Lancet.

[12]  J. Wildmann.  Increase of natural benzodiazepines in wheat and potato during germination. , 1988, Biochemical and biophysical research communications.

[13]  C. Madl,et al.  IMPROVEMENT OF HEPATIC ENCEPHALOPATHY TREATED WITH FLUMAZENIL , 1988, The Lancet.

[14]  R. Maurer,et al.  Occurrence of pharmacologically active benzodiazepines in trace amounts in wheat and potato. , 1988, Biochemical pharmacology.

[15]  P. Skolnick,et al.  Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  J. Medina,et al.  Presence of benzodiazepine-like molecules in mammalian brain and milk. , 1988, Biochemical and biophysical research communications.

[17]  W. Mendelson,et al.  COULD AN ENDOGENOUS BENZODIAZEPINE LIGAND CONTRIBUTE TO HEPATIC ENCEPHALOPATHY? , 1988, The Lancet.

[18]  P. Skolnick,et al.  Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. , 1987, Gastroenterology.

[19]  C. Sotelo,et al.  Localization of benzodiazepine-like molecules in the rat brain. A light and electron microscopy immunocytochemistry study with an anti-benzodiazepine monoclonal antibody , 1987, Brain Research.

[20]  Dongeun Park,et al.  Endogenous benzodiazepine-like molecules in the human, rat and bovine brains studied with a monoclonal antibody to benzodiazepines , 1987, Brain Research.

[21]  H. Fales,et al.  Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Manchon,et al.  Evaluation of EMIT-TOX Enzyme Immunoassay for the analysis of benzodiazepines in serum: usefulness and limitations in an emergency laboratory. , 1985, Journal of analytical toxicology.

[23]  L. Sangameswaran,et al.  Demonstration of benzodiazepine-like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Meier,et al.  REVERSAL OF HEPATIC COMA BY BENZODIAZEPINE ANTAGONIST (Ro 15-1788) , 1985, The Lancet.

[25]  J. Biebuyck,et al.  Portacaval Anastomosis: Brain and Plasma Metabolite Abnormalities and the Effect of Nutritional Therapy , 1984, Journal of neurochemistry.

[26]  M. Baraldi,et al.  Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. , 1984, Clinical science.

[27]  H. Przuntek,et al.  Endogenous benzodiazepine ligands in human cerebrospinal fluid , 1984, Peptides.

[28]  J. Hoofnagle,et al.  SERUM LEVELS OF GAMMA-AMINOBUTYRIC-ACID-LIKE ACTIVITY IN ACUTE AND CHRONIC HEPATOCELLULAR DISEASE , 1983, The Lancet.

[29]  M. Baraldi,et al.  Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid. , 1982, Science.

[30]  E. Jones,et al.  HEPATIC ENCEPHALOPATHY AND THE γ-AMINOBUTYRIC-ACID NEUROTRANSMITTER SYSTEM , 1982, The Lancet.

[31]  R. Olsen.  GABA‐Benzodiazepine‐Barbiturate Receptor Interactions , 1981, Journal of neurochemistry.

[32]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[33]  S. Spector,et al.  Quantitative determination of diazepam in blood by radioimmunoassay. , 1973, The Journal of pharmacology and experimental therapeutics.

[34]  U. Klotz.  Occurrence of "natural" benzodiazepines. , 1991, Life sciences.

[35]  U. Klotz,et al.  Occurrence of 'natural' diazepam in human brain. , 1990, Biochemical pharmacology.

[36]  P. Meier,et al.  Effects Of The Benzodiazepine Antagonist Flumazenil In Hepatic Encephalopathy in Man , 1989 .

[37]  R. Butterworth,et al.  Effect of Portacaval Anastomosis on Ammonia Metabolism in Brain and Liver , 1989 .

[38]  P. Ferenci,et al.  Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. , 1989, Gastroenterology.

[39]  J. Krystal,et al.  Psychopharmacology: The Third Generation of Progress , 1989, The Yale Journal of Biology and Medicine.

[40]  D. Häussinger,et al.  Overestimation of serum concentrations of γ‐aminobutyric acid in patients with hepatic encephalopathy by the γ‐aminobutyric acid‐radioreceptor assay , 1988 .

[41]  A. Lockwood.  Hepatic encephalopathy: experimental approaches to human metabolic encephalopathy. , 1987, Critical reviews in neurobiology.

[42]  E. Jones,et al.  Hepatic encephalopathy: a neurochemical disorder. , 1986, Progress in liver diseases.

[43]  P. Skolnick,et al.  High-performance fast affinity chromatographic purification of anti-benzodiazepine antibodies. , 1986, Journal of Chromatography A.

[44]  C. Chichester,et al.  Quantification of collagen synthesis by reversed-phase high-performance liquid chromatography utilizing 4-chloro-7-nitrobenzofurazan derivatives. , 1986, Journal of chromatography.

[45]  S. Olszowski,et al.  A possible origin of chemiluminsecence in phagocytosing neutrophils. Myeloperoxidase-mediated chlorination of proteins and tryptophan. , 1985, The International journal of biochemistry.

[46]  Professor Dr. Martin Luckner.  Secondary Metabolism in Microorganisms, Plants and Animals , 1984, Springer Berlin Heidelberg.

[47]  G. Scollo-Lavizzari.  First clinical investigation of the benzodiazepine antagonist Ro 15-1788 in comatose patients. , 1983, European neurology.

[48]  S. Garattini,et al.  Benzodiazepines receptor binding in vivo: pharmacokinetic and pharmacological significance. , 1983, Advances in biochemical psychopharmacology.

[49]  E. Jones,et al.  Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. , 1982, Lancet.

[50]  R. George.  Improved sample treatment before liquid-chromatographic determination of anticonvulsants in serum. , 1981, Clinical chemistry.